⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CORT News
Corcept Therapeutics Inc.
Pomerantz LLP Informs Shareholders of Class Action Against Corcept Therapeutics Incorporated – CORT
accessnewswire.com
CORT
CORT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Corcept Therapeutics Incorporated Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
CORT
Pomerantz LLP Informs Shareholders of Class Action Against Corcept Therapeutics Incorporated – CORT
accessnewswire.com
CORT
Corcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session
businesswire.com
CORT
Pomerantz LLP Notifies Investors of Class Action Against Corcept Therapeutics Incorporated – CORT
accessnewswire.com
CORT
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
prnewswire.com
CORT
CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss
globenewswire.com
CORT
Pomerantz LLP Notifies Investors of Class Action Against Corcept Therapeutics Incorporated – CORT
accessnewswire.com
CORT
DEADLINE ALERT for PYPL, SMR, CORT, NAVN: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
globenewswire.com
CORT
NAVN
PYPL
SMR
Bronstein, Gewirtz & Grossman LLC Urges Corcept Therapeutics Incorporated Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
CORT